Nutrigenomics: Georges Mouton on eating for your genes
Dr Georges Mouton explains why eating according to your genotype changes everything for digestion, the heart and the brain.

By Benjamin Sant · Updated on 21 November 2026
A simple plate of spaghetti bolognese can trigger bloating, abdominal pain and intestinal upset in certain people, without this being a classic allergy or intolerance. The culprit is hiding in the DNA. This is one of the striking messages delivered by Dr Georges Mouton, a pioneer of functional medicine in Europe for more than forty years, in a fascinating conversation about nutrigenomics, the science that links our genes to our plate.
Watch the full episode on YouTube
Functional medicine looks for the cause rather than treating the symptom
Trained in sports medicine before moving into functional medicine in the early nineties, Dr Mouton says he quickly grew disillusioned with an allopathic medicine that, in his view, locks itself into a reductive triad: a symptom, a diagnosis, a drug. He even recalls waiting rooms where patients were asked to raise only one complaint per consultation, having to book another appointment for the rest. An absurdity, in his view, when the combination of symptoms, family history and lifestyle paints a much richer clinical picture.
This approach does not reject conventional medicine, however. Dr Mouton stresses its absolute necessity in acute or serious conditions, citing the example of a severe case of meningitis treated within a colleague’s family. He now prefers to speak of integrative medicine, which combines the best of both worlds rather than pitting them against each other, much like the Mayo Clinic, which has built this philosophy into its academic approach.
In practice, this approach rests on in-depth dietary investigation, family medical history over two generations, and thorough blood tests that reveal irrefutable facts: nutritional deficiencies, inflammation, oxidation, microbiota disruption or unfavourable fatty acid profiles. The ultimate goal remains the same: building a bespoke programme, never a standardised protocol.
Four food genotypes dictate rules that cannot be ignored
For twelve years, Dr Mouton has systematically tested four key genotypes presented in his book Je mange selon mes génotypes (I eat according to my genotypes): ApoE, DIO2, AMY1A and the LCT or MCM6 gene linked to lactose tolerance. Unlike classic biological markers, these genes never change. You are born with them and you die with them, he reminds us, dismissing in passing the common belief that epigenetics could alter a genotype over the course of a lifetime.
The AMY1A genotype perfectly illustrates his point. It determines how much salivary amylase a person produces, and therefore their capacity to digest starches. Someone who produces little of it will not tolerate a dish where spaghetti heavily outweighs the bolognese sauce, or a risotto laden with rice and few mushrooms. Undigested starches then feed a microbiota that runs riot and proliferates, causing an intestinal upset that Dr Mouton compares to lactose intolerance: bloating, diarrhoea, abdominal pain, reflux. Small amounts pass without issue, but as soon as someone « goes for it properly », the body can no longer keep up.
The ApoE and DIO2 genes play a different role, more focused on the balance of macronutrients. They indicate whether a person would benefit from increasing the proportion of fat in their diet, a central question at a time when ketogenic and carnivore diets are becoming more widespread. Not everyone is suited to this type of diet, warns the doctor, who is wary of dietary « honeymoon phases » that sometimes end in disappointment after a few months.
The ApoE gene weighs heavily on cardiovascular and neurodegenerative risk
Among the four genotypes tested, ApoE occupies a special place. Three variants exist: ApoE3, by far the most common and considered neutral, ApoE2, rarer and associated with better longevity, and ApoE4, found in around a fifth of the population in our regions. This last variant carries a greater predisposition to cardiovascular disease and neurodegeneration, particularly Alzheimer’s disease.
But Dr Mouton is adamant: this is in no way a foregone conclusion. He points out that genes account for only a limited share, estimated at between twenty and thirty per cent, of what is known as the phenotype, the final observable outcome in a person. Everything else comes down to epigenetics, in other words lifestyle: diet, sleep, stress management, light exposure, physical activity. Populations carrying ApoE4 in Africa, who do not eat processed meats or excess saturated fat, suffer very little from neurodegenerative disease as a result.
Knowing your ApoE status therefore allows you to adjust your lifestyle with full knowledge rather than navigating blindly. Dr Mouton says he has long followed patients carrying ApoE4 who, thanks to targeted adjustments, do not go on to develop Alzheimer’s disease. Conversely, the rare carriers of ApoE2 must absolutely increase their fat intake, or risk developing multiple disorders if they remain locked into the carbohydrate-dominated eating pattern typical of our modern Neolithic era.
A saliva test is enough and costs no more than two hundred euros
Unlike an annual blood test that tracks fluctuating biological markers, the genetic test only needs to be done once in a lifetime, since DNA does not change. Dr Mouton explains that this is a non-invasive saliva analysis, just as reliable as a blood test, carried out using oral epithelial cells.
In France, the situation remains complicated, since recreational DNA tests are banned and can be stopped at customs. But tests carried out for medical purposes, prescribed by a registered healthcare professional, are exempt from this ban when performed in a European country where they are legal, Belgium, Spain or Germany, for example. Dr Mouton does, however, warn against large commercial genetic panels driven by artificial intelligence, which sometimes recommend selenium supplementation without taking a person’s actual diet into account, which can lead to needless or even dangerous excesses.
Beyond the four central genotypes, other markers interest the doctor on a case-by-case basis, such as the FUT2 gene, which governs fucose secretion in the gut and affects close to a fifth of the population suffering from chronic digestive disorders, constipation or autoimmune conditions. Measuring immunoglobulin A, linked to the protection of the intestinal lining, sometimes completes this picture for the most stubborn digestive cases.
Lipoprotein little a reveals a cardiovascular risk that stays silent
During the conversation, Dr Mouton mentions a little-known but crucial marker, lipoprotein little a, which is strongly hereditary and stable over time, and therefore also only needs to be measured once in a lifetime. A high level signals an increased cardiovascular risk for which medicine still has few direct therapeutic levers, but which warrants heightened vigilance: blood pressure monitoring, carotid ultrasound from the age of forty or forty-five, and particular attention paid to muscle mass, a genuine ally in cardiovascular prevention.
He also stresses the need to systematically cross-check lipid markers with the carbohydrate profile, in particular glycated haemoglobin and fasting insulin, to avoid a cardiovascular risk profile being compounded by silent insulin resistance. Someone with a high lipoprotein little a level would do well, in his view, to also check their ApoE status, the two pieces of information combining to fine-tune dietary strategy.
On the subject of omega-3s, Dr Mouton and the podcast host highlight the importance of small oily fish such as sardines, mackerel and anchovies, safer than salmon or tuna when it comes to heavy metals, as well as the value of eggs and meat from pasture-raised animals, whose omega-6 to omega-3 ratio can vary by a factor of ten depending on their diet.
Palaeogenomics sheds light on the origin of our digestive differences
Dr Mouton is enthusiastic about a still-young discipline, palaeogenomics, which in two thousand and twenty-two made it possible to show that all humans, around twenty-five thousand years ago, shared what is known as an ancestral DIO2 genotype, perfectly suited to a diet low in starch and high in fat, which made sense at a time when agriculture did not yet exist. This discovery, based on the decoding of ancient DNA, earned a Nobel Prize in Medicine in two thousand and twenty.
The same phenomenon is seen with salivary amylase, whose number of genetic copies broadly increased between the Palaeolithic and Neolithic periods, as the human diet became richer in cereals. But there is no way of guessing, in a given person today, whether they have retained an ancestral or a modern version of these genes without taking the test. That is the whole point of this approach: personalising instead of guessing.
Dr Mouton concludes with a piece of advice that might seem to run against the grain of his own profession: learning to listen to yourself. Too many people blindly follow generic recommendations, whether intermittent fasting or the supposedly compulsory breakfast, without paying attention to their own hunger and fullness signals. Medical and genomic expertise should, in his view, work alongside this bodily awareness, never replace it.
Watch the full episode on YouTube
Taking action
Eating according to your genotypes is no gimmick but a concrete prevention approach, backed by decades of clinical practice. It remains for each person to explore, carefully and with medical support, what their DNA has to say about their plate.
These pointers are a matter of prevention and lifestyle, alongside medical follow-up and never in its place. For an approach tailored to your situation, discover Elite Longevity’s support programmes. Details are provided during an initial conversation.
Sources
The podcast conversation with Georges Mouton, whose full episode is available on YouTube, is the primary source for this article. The references below document the topics it covers.
Scientific references on the topic
- Polymorphisms, diet and nutrigenomics. J Prev Med Hyg, 2022.
- Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition. Int J Mol Sci, 2023.
- Genetics, Nutrition, and Health: A New Frontier in Disease Prevention. J Am Nutr Assoc, 2024.
- Precision Nutrition: Recent Advances in Obesity. Physiology (Bethesda), 2023.
Frequently asked questions
What exactly is nutrigenomics?
Nutrigenomics is the branch of genetics that studies how certain genes influence the ability to digest and metabolise food. It helps identify predispositions, such as low salivary amylase production, so that diet can be adjusted accordingly to avoid recurring digestive or metabolic problems.
Is a dietary genetic test legal in France?
Recreational DNA tests are banned in France and can be stopped at customs. However, a test carried out for medical purposes, prescribed by a registered healthcare professional and performed in a laboratory in another European country where it is legal, such as Belgium or Spain, is entirely permitted for a French resident.
What does the ApoE4 genotype actually mean?
The ApoE4 genotype is associated with an increased risk of cardiovascular disease and neurodegeneration, particularly Alzheimer’s disease. However, this is not a foregone conclusion: according to Dr Mouton, a suitable lifestyle, limiting alcohol, tobacco and saturated fats, can considerably reduce this risk.
Why do some people digest starches poorly?
This often depends on the AMY1A gene, which determines how much salivary amylase a person produces. Low production limits the capacity to digest large amounts of starch, with undigested starches then fermented by the microbiota, causing bloating and intestinal problems, a mechanism similar to lactose intolerance.
Does a genetic test need to be repeated regularly like a blood test?
No, unlike blood panels, which change and are repeated every year, the genetic test only needs to be carried out once in a lifetime since DNA remains stable. Only the interpretation of the results may become more refined as scientific research progresses.
What is lipoprotein little a and why should it be monitored?
Lipoprotein little a is a strongly hereditary marker that is stable over time and signals an increased cardiovascular risk when levels are high. Detecting it warrants heightened monitoring, in particular a carotid ultrasound and closer tracking of overall glucose and lipid profiles.
Latest from the blog
Read next
Insulin resistance: Jérôme Perottet explains the mechanism
Jérôme Peroté, physiotherapist and nutritionist, explains why insulin resistance affects even people who eat little sugar, and how to detect…
Read the article
Stem cells: Christian Drapeau’s secret to repair
Christian Drapeau, a neurophysiology researcher, explains how to stimulate your own stem cells to slow ageing naturally.
Read the article
Legs, skin, longevity: Dr Valérie Le Duc’s secrets after 50
Dr Valérie Leduc, a vascular physician, shares her secrets for healthy legs and skin after 50, without major surgery.
Read the article